# Reduced Intensity AlloSCT in(CML) With Persistent Disease

> **NCT00531310** · PHASE2 · TERMINATED · sponsor: **Columbia University** · enrollment: 5 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Reduced Intensity Conditioning, Busulfan and Fludarabine

## Key facts

- **NCT ID:** NCT00531310
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2007-12
- **Final completion:** 2010-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531310, "Reduced Intensity AlloSCT in(CML) With Persistent Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00531310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*